Kenotas Labs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-01-2025
- Paid Up Capital ₹ 0.10 M
as on 05-01-2025
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2020)
- Profit -1.74%
(FY 2020)
- Ebitda -1.74%
(FY 2020)
- Net Worth -7.26%
(FY 2020)
- Total Assets -6.87%
(FY 2020)
About Kenotas Labs
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Uttam Sharma, Kiran Sharma, Shardendu Bhardwaj, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304UP2017PTC098690
- Company No.
098690
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gorakhpur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kenotas Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uttam Sharma  | Managing Director | 20-Nov-2017 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiran Sharma | Director | 20-Nov-2017 | Current |
| Shardendu Bhardwaj | Additional Director | 12-Feb-2020 | Current |
| Vagish Tripathi | Additional Director | 12-Feb-2020 | Current |
Financial Performance of Kenotas Labs.
Kenotas Labs Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 1.74% decrease in profit. The company's net worth dipped by a decrease of 7.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kenotas Labs?
Unlock access to Kenotas Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Astrazest Pharma Private LimitedActive 4 years 4 daysShardendu Bhardwaj and Vagish Tripathi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kenotas Labs?
Unlock and access historical data on people associated with Kenotas Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kenotas Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kenotas Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
